These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
94 related articles for article (PubMed ID: 21507473)
21. Lymph-vascular space invasion as a significant risk factor for isolated para-aortic lymph node metastasis in endometrial cancer: a study of 203 consecutive patients. Chang SJ; Kong TW; Kim WY; Yoo SC; Yoon JH; Chang KH; Ryu HS Ann Surg Oncol; 2011 Jan; 18(1):58-64. PubMed ID: 20607418 [TBL] [Abstract][Full Text] [Related]
22. [Pelvic lymphadenectomy as an alternative to adjuvant radiotherapy in early stage endometrial cancer at high risk of recurrent lymphatic metastases (stage I)]. Amato NA; Partipilo V; Mele F; Boscia F; De Marzo P Minerva Ginecol; 2009 Feb; 61(1):1-12. PubMed ID: 19204656 [TBL] [Abstract][Full Text] [Related]
23. [Multivariate analysis of prognostic factors in endometrial carcinoma]. Li B; Wu LY; Li SM; Zhang WH; Zhang R; Ma SK Ai Zheng; 2004 Sep; 23(9):1085-8. PubMed ID: 15363208 [TBL] [Abstract][Full Text] [Related]
24. Systematic pelvic and aortic lymphadenectomy in intermediate and high-risk endometrial cancer: lymph-node mapping and identification of predictive factors for lymph-node status. Fotopoulou C; Savvatis K; Kraetschell R; Schefold JC; Lichtenegger W; Sehouli J Eur J Obstet Gynecol Reprod Biol; 2010 Apr; 149(2):199-203. PubMed ID: 20096987 [TBL] [Abstract][Full Text] [Related]
25. Pelvic lymph node count is an important prognostic variable for FIGO stage I and II endometrial carcinoma with high-risk histology. Lutman CV; Havrilesky LJ; Cragun JM; Secord AA; Calingaert B; Berchuck A; Clarke-Pearson DL; Soper JT Gynecol Oncol; 2006 Jul; 102(1):92-7. PubMed ID: 16406063 [TBL] [Abstract][Full Text] [Related]
26. Endometrial carcinosarcomas have a different prognosis and pattern of spread compared to high-risk epithelial endometrial cancer. Amant F; Cadron I; Fuso L; Berteloot P; de Jonge E; Jacomen G; Van Robaeys J; Neven P; Moerman P; Vergote I Gynecol Oncol; 2005 Aug; 98(2):274-80. PubMed ID: 15972232 [TBL] [Abstract][Full Text] [Related]
27. Use of preoperative serum CA-125 levels for prediction of lymph node metastasis and prognosis in endometrial cancer. Chung HH; Kim JW; Park NH; Song YS; Kang SB; Lee HP Acta Obstet Gynecol Scand; 2006; 85(12):1501-5. PubMed ID: 17260229 [TBL] [Abstract][Full Text] [Related]
28. Stage II endometrial carcinoma: limiting post-operative radiotherapy to the vaginal vault in node-negative tumors. Rittenberg PV; Lotocki RJ; Heywood MS; Krepart GV Gynecol Oncol; 2005 Sep; 98(3):434-8. PubMed ID: 16005498 [TBL] [Abstract][Full Text] [Related]
29. Robot-assisted laparoscopic staging surgery for endometrial cancer--a preliminary report. Lee CL; Han CM; Su H; Wu KY; Wang CJ; Yen CF Taiwan J Obstet Gynecol; 2010 Dec; 49(4):401-6. PubMed ID: 21199739 [TBL] [Abstract][Full Text] [Related]
30. Role of systematic lymphadenectomy and adjuvant radiation in early-stage endometrioid uterine cancer. Jeong NH; Lee JM; Lee JK; Kim MK; Kim YJ; Cho CH; Kim SM; Park SY; Park CY; Kim KT Ann Surg Oncol; 2010 Nov; 17(11):2951-7. PubMed ID: 20556522 [TBL] [Abstract][Full Text] [Related]
32. Initial failure site according to primary treatment with or without para-aortic lymphadenectomy in endometrial cancer. Todo Y; Kato H; Minobe S; Okamoto K; Suzuki Y; Sudo S; Takeda M; Watari H; Kaneuchi M; Sakuragi N Gynecol Oncol; 2011 May; 121(2):314-8. PubMed ID: 21315429 [TBL] [Abstract][Full Text] [Related]
33. An intensive follow-up does not change survival of patients with clinical stage I endometrial cancer. Gadducci A; Cosio S; Fanucchi A; Cristofani R; Genazzani AR Anticancer Res; 2000; 20(3B):1977-84. PubMed ID: 10928137 [TBL] [Abstract][Full Text] [Related]
34. Routes of lymphatic spread: a study of 112 consecutive patients with endometrial cancer. Mariani A; Webb MJ; Keeney GL; Podratz KC Gynecol Oncol; 2001 Apr; 81(1):100-4. PubMed ID: 11277658 [TBL] [Abstract][Full Text] [Related]
36. A pilot study of sentinel lymph nodes identification in patients with endometrial cancer. Li B; Li XG; Wu LY; Zhang WH; Li SM; Min C; Gao JZ Bull Cancer; 2007 Jan; 94(1):E1-4. PubMed ID: 17236998 [TBL] [Abstract][Full Text] [Related]
37. [Study on cytokeratin and CA125 for diagnosing lymph node micrometastases in endometrial cancer]. Liu FH; Wang YF; Wang J; Xue Q; Jiang S; Ma YY Zhonghua Fu Chan Ke Za Zhi; 2004 Sep; 39(9):612-5. PubMed ID: 15498190 [TBL] [Abstract][Full Text] [Related]
38. Percent surface area involvement is a predictor of lymph node metastasis in endometrial cancer. Axtell AE; Kelley JL; Fader AN; Gupta D; Schwartz B; Comerci JT; Lin Y; Weiand S; Gallion HH; Kanbour-Shakir A Gynecol Oncol; 2007 Dec; 107(3):482-6. PubMed ID: 17850853 [TBL] [Abstract][Full Text] [Related]